Join ISA on April 29th at Visionloft Stutz to hear more details about the upcoming Medicine Foundry from Eli Lilly and Company. This project has an overall value of $4,500,000,000.
The Medicine Foundry project involves a 200-acre clinical trial manufacturing campus that will expand Lilly’s capabilities in producing small molecules, oligonucleotides, peptides, and ADCs. The Foundry will enhance Lilly’s supply chain and reduce reliance on external partners. This facility is critical for accelerating innovation, improving flexibility in portfolio decisions, and increasing supply chain resilience, ensuring more control over production and delivery.
Foundry Partners will be there to share more information about the project, as well as bidding details.
REGISTER HERE
AGENDA
2:30 PM | Registration
3:00 PM | Presentation
4:00 PM | Open Networking
5:00 PM | Event Ends
ATTENDEE LIST
Notifications